DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). of veins during ablation procedures with far fewer energy applications than on-market competitive PFA systems. Procedural flexibility.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Ablation Cardiomyopathy Heart Failure 64

DAIC

JULY 24, 2024

The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Introduction A high recurrence rate of atrial fibrillation was monitored after catheter ablation for persistent atrial fibrillation. The results will evaluate sacubitril/valsartan as a novel treatment for improving prognosis and a complement to conventional drug therapy.

Atrial Fibrillation 64

Atrial Fibrillation Heart Failure Ablation Electrocardiogram 64

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 68

AFIB Ablation Atrial Fibrillation Outcomes 68

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

2 at this year's ESC Congress 2024.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Tachycardia 40

HeartRhythm

APRIL 30, 2024

Catheter Ablation for Atrial Fibrillation (AFib) in heart failure is now a class I indication for patients with heart failure. Evidence supports the relationship between obesity and the incidence and recurrence of Afib.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Obesity Ablation 40

Circulation

OCTOBER 13, 2024

Circulation, Volume 150, Issue 16 , Page 1220-1222, October 15, 2024.

Atrial Fibrillation 81

Atrial Fibrillation Heart Failure Ablation Circulation 81

HeartRhythm

OCTOBER 21, 2024

Clinical outcomes among patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) treated with catheter ablation (CA) versus antiarrhythmic therapy (AAT) are not well-known.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

DAIC

MARCH 5, 2024

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation 5. Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device 6. Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure 8.

Heart Failure 111

Heart Failure Atrial Fibrillation Interventional Cardiology Heart Valves 111

HeartRhythm

MAY 2, 2024

The optimal treatment for atrial fibrillation (AF) in patients with heart failure with reduced ejection fraction (HFrEF) remains unsettled.

Atrial Fibrillation 45

Atrial Fibrillation Heart Failure Ablation 45

DAIC

JUNE 4, 2024

American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged 3.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

HeartRhythm

SEPTEMBER 25, 2024

Atrial fibrillation (AF) is a common reversible cause of worsening left ventricular ejection fraction (LVEF) in patients with heart failure. Guidelines propose a class 1 recommendation for AF catheter ablation (CA) in patients with heart failure with reduced ejection fraction1,2.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). Catheter ablation of AF has been proven to be an effective therapeutic option for AF management in HF, particularly in heart failure with reduced ejection fraction (HFrEF) [2, 3].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). whether ablation is mandatory or pointless in patients who have HF).

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

The efficacy of catheter ablation as a treatment approach for patients with concurrent atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) has been inadequately investigated.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) for atrial fibrillation (AF) and heart failure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Quality of Life 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Overview of the study population and effects observed after catheter ablation for atrial fibrillation. Herein we describe the effects of catheter ablation on AF burden, arrhythmia recurrences, and ventricular function in end-stage HF. to 39.18.3% ( p <0.001) following ablation. PVI, pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

HeartRhythm

APRIL 14, 2024

The benefit of catheter ablation in patients with atrial fibrillation (AF) for patients with heart failure with preserved ejection fraction (HFpEF) remains uncertain.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

NOVEMBER 5, 2024

Recent trial results led to a renewed consideration of rhythm control therapy to improve outcomes in patients with atrial fibrillation (AF)1,2. The resulting shift towards rhythm control therapy for most patients with atrial fibrillation is reflected by new recommendations in the recent ESC3 and ACC/AHA/HRS4 AF guidelines.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Strokes 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 26, 2024

ABSTRACT Introduction Atrial fibrillation (AF) can cause or aggravate heart failure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent AF ablation performed during hospitalization for acute HF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Hospital 40

HeartRhythm

AUGUST 18, 2024

The impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF) recurrence outcomes and adverse cardiovascular outcomes in heart failure (HF) patients after AF ablation is unknown.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

Rate vs Rhythm Control in Atrial Fibrillation Rate vs rhythm control as a management strategy in atrial fibrillation has been a long standing topic for debate. AF-CHF trial in those with AF and congestive heart failure also failed to show any advantage for the rhythm control strategy [3].

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest 52

DAIC

MAY 3, 2024

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say 4. Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease 6. 24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack 10. EMPACT-MI Trial Outcomes Reported at ACC.24:

Blood Pressure 105

Blood Pressure Angioplasty Heart attacks Heart Attack 105

HCPLive

APRIL 26, 2024

A meta-analysis of 12 trials suggests catheter ablation for atrial fibrillation reduces heart failure events in HFrEF patients but not in HFpEF.

Ablation 59

Ablation Atrial Fibrillation AFIB Heart Failure 59

DAIC

JANUARY 5, 2024

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation 3. Atrial Fibrillation Market Reaches $20.92B, According to New Report 9. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study

Atrial Fibrillation 105

Atrial Fibrillation Aortic valve Cardiothoracic Interventional Cardiology 105

HeartRhythm

APRIL 30, 2024

Studies have suggested that early atrial fibrillation (AF) ablation is associated with improved outcomes. However, it is unknown whether these patterns hold for persistent AF among patients with heart failure with preserved ejection fraction (HFpEF). The majority of these studies evaluated paroxysmal AF cases.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

European Journal of Heart Failure

NOVEMBER 3, 2024

Abstract Aims Atrial fibrillation (AF) is common in heart failure (HF) and negatively impacts outcomes. The role of ablation-based rhythm control in patients with AF and HF with preserved (HFpEF) or mildly reduced ejection fraction (HFmrEF) is not known.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

MAY 2, 2024

The authors claim that their score identifies heart failure (HF) patients who benefit the most from atrial fibrillation (AF) ablation. in favour of ablation in the “high-risk group” and 0.41 However, the crude hazard ratio (HR) for the primary endpoint was 0.32 in the “low-risk group”.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

American College of Cardiology

APRIL 24, 2024

The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.

Atrial Fibrillation 63

Atrial Fibrillation Heart Failure Electrophysiology Ablation 63

HeartRhythm

APRIL 30, 2024

Previous studies have demonstrated significant morbidity and mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), particularly with accompanying atrial fibrillation (AF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 9, 2024

Atrial fibrillation (AF) and heart failure (HF) frequently coexist. Prediction of left ventricular ejection fraction (LVEF) recovery after catheter ablation (CA) for AF remains difficult.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Biomarkers Heart Failure 40

HeartRhythm

APRIL 30, 2024

Left atrial and pulmonary artery pressure (PAP) elevation can reflect severity and dynamic status of heart failure (HF) in HF with preserved ejection fraction (pEF). Atrial fibrillation (AF) worsens HFpEF progression and pump failure, but catheter ablation can restore rhythm control in this population.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Open Heart

AUGUST 4, 2023

Objective This study aims to leverage natural language processing (NLP) and machine learning clustering analyses to (1) identify co-occurring symptoms of patients undergoing catheter ablation for atrial fibrillation (AF) and (2) describe clinical and sociodemographic correlates of symptom clusters. female, 58% white).

Atrial Fibrillation 52

Atrial Fibrillation Ablation Chest Pain Document 52

Journal of Cardiovascular Electrophysiology

OCTOBER 21, 2024

Abstract Introduction Catheter ablation for atrial fibrillation (AF) reduces heart failure (HF) hospitalization in patients with HF with preserved ejection fraction (HFpEF). However, the long-term outcomes and subclinical HF after nonparoxysmal AF ablation in HFpEF patients have not been fully evaluated.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Open Heart

JANUARY 18, 2024

Background The Heart Failure Association Pretest assessment, echocardiography and natriuretic peptide, functional testing and final aetiology (HFA-PEFF) score has been developed for diagnosing heart failure with preserved ejection fraction (HFpEF), which is frequently associated with atrial fibrillation (AF).

Atrial Fibrillation 52

Atrial Fibrillation Preserved Ejection Fraction Ablation Outcomes 52